Darwin Global Management, Ltd. Nurix Therapeutics, Inc. Transaction History
Darwin Global Management, Ltd.
- $1.06 Billion
- Q4 2024
A detailed history of Darwin Global Management, Ltd. transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Darwin Global Management, Ltd. holds 163,681 shares of NRIX stock, worth $2.74 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
163,681Holding current value
$2.74 Million% of portfolio
0.29%Shares
1 transactions
Others Institutions Holding NRIX
# of Institutions
184Shares Held
70.6MCall Options Held
318KPut Options Held
42.4K-
Black Rock Inc. New York, NY6.82MShares$114 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$72.7 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.19MShares$70.1 Million6.18% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$64.9 Million0.81% of portfolio
-
Wellington Management Group LLP Boston, MA3.59MShares$60 Million0.01% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $789M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...